Related by context. All words. (Click for frequent words.) 77 A1c 77 hemoglobin A1C 75 HbA1C 74 glycated hemoglobin 74 hemoglobin A1c HbA1c 73 HbA 1c 72 hemoglobin A1c levels 72 HbA1c 71 A1C 71 HbA1c levels 70 A1C levels 69 glycated hemoglobin HbA1c 68 glycosylated hemoglobin 68 glycosylated hemoglobin HbA1c 68 glycated hemoglobin levels 68 A1c levels 67 fasting plasma glucose 67 HbA 1c levels 67 serum potassium 67 Hemoglobin A1C 66 Hb A1C 65 fasting blood glucose 65 Hemoglobin A1c 65 Hb A1c 65 OGTT 65 fasting glucose 65 Fasting glucose 65 baseline HbA1c 65 creatinine 64 urine albumin 64 urinary albumin 64 HbA1C levels 64 glycemia 64 antihypertensive medications 64 exhaled nitric oxide 64 atherogenic dyslipidemia 63 glomerular filtration rate 63 HOMA IR 63 eGFR 63 blood glucose 63 #/#mmHg 62 elevated LDL cholesterol 62 oral glucose tolerance 62 hs CRP 62 serum urate 62 cystatin C 62 microalbumin 62 #mg/dL [001] 61 serum creatinine levels 61 fasting plasma glucose FPG 61 serum phosphorus 61 #.#mmol L [002] 61 alanine aminotransferase ALT 61 lipid levels 61 serum glucose 61 hypertensives 60 fasting glucose levels 60 serum uric acid 60 C reactive protein 60 serum PSA 60 calculated creatinine clearance 60 mg dL 60 creatinine levels 60 nonfasting triglyceride levels 60 platelet reactivity 60 serum ferritin 60 serum phosphate 60 hsCRP levels 60 HbA 1C 60 microalbuminuria 60 sUA 60 intima media thickness 60 serum phosphorous 60 troponin T 60 #mmHg [001] 60 ejection fractions 60 cTnT levels 59 D dimer 59 elevated triglycerides 59 Prostate Specific Antigen PSA 59 glycosylated hemoglobin levels 59 albumin excretion rate 59 albumin excretion 59 #.#mmol l [002] 59 serum creatinine 59 hsCRP 59 estimated GFR 59 Prostate Specific Antigen 59 urinary albumin excretion 59 nondiabetic patients 59 μg dL 59 triglyceride concentrations 59 mmol l 59 baseline A1C 59 microvascular complications 59 total cholesterol triglycerides 59 albuminuria 59 LDL cholesterol 59 albumin creatinine ratio 59 pulmonary capillary wedge 59 nonfasting 59 eNO 59 serum triglyceride levels 58 hemoglobin hematocrit 58 neutrophil counts 58 estimated glomerular filtration 58 glulisine 58 DASH diet 58 HDL Cholesterol 58 fecal occult blood 58 #mg/dl 58 glomerular filtration 58 procalcitonin 58 hydroxy vitamin D 58 HDL LDL 58 lymphocyte count 58 #mg/dL [002] 58 NT proBNP 58 fasting insulin 58 K DOQI 58 LVEF 58 elevated uric acid 58 Lantus ® 58 mEq L 58 systolic pressure 58 cholesterol LDL C 58 proteinuria 58 mmHg diastolic 58 BENICAR HCT 58 mmol L. 58 #mmHg [002] 58 LDL HDL 58 MMSE scores 58 serum lipid levels 58 mm Hg systolic 58 antihypertensive drugs 58 NATRECOR R 58 elevated fasting glucose 58 total cholesterol LDL 58 serum phosphate levels 58 leukocyte count 58 iPTH 58 PSADT 58 serum sodium 58 FeNO 58 LDL C 58 fingerstick 58 serum calcium 57 intact parathyroid hormone 57 PSA nadir 57 hypertensive patients 57 thiazide diuretics 57 serum bilirubin 57 SCr 57 Crohn Disease Activity 57 BENICAR 57 prescribed statin 57 peak VO2 57 1c HbA 1c 57 hydroxyvitamin D levels 57 mm Hg diastolic 57 systolic BP 57 elevated CRP 57 mU L 57 resistant hypertension 57 creatinine ratio 57 Kidney Disease Outcomes 57 transferrin saturation 57 carotid IMT 57 mL/min/#.# m 2 57 blood glucose levels 57 Fasting blood glucose 57 MDRD equation 57 fasting triglyceride levels 57 triglyceride concentration 57 apolipoprotein B 57 macroalbuminuria 57 NCEP ATP III 57 fasting triglycerides 57 elevated creatinine 57 A1Cs 57 blood sugar 57 Visual acuity 57 lispro 57 serum urate levels 57 NPH insulin 57 urine cytology 57 exhaled NO 57 LDL Cholesterol 57 kidney function 57 alanine aminotransferase 57 overt nephropathy 57 pCR 57 intensive statin therapy 57 aspartate aminotransferase AST 57 cardiovascular mortality 57 aldosterone antagonist 57 lipid parameters 57 elevated ALT 57 C Reactive Protein 57 sweat chloride 57 PT INR 57 impaired fasting glucose 56 CrCl 56 serum triglycerides 56 #.#/#.# mmHg [001] 56 #.#ng/ml 56 creatinine clearance 56 prostate specific antigen 56 liver histology 56 Triglyceride levels 56 per deciliter mg 56 digital rectal examination 56 cholesterol HDL 56 lipid profile 56 lipoprotein levels 56 ng dL 56 baseline serum creatinine 56 antihypertensive therapy 56 macrovascular events 56 oral antidiabetic medication 56 cholesterol LDL 56 NYHA functional class 56 postoperative mortality 56 Score IPSS 56 CK MB 56 mg dl 56 antigen PSA 56 -#.# mg dL [002] 56 mmol L 56 PSA prostate 56 LDL triglycerides 56 hypertension 56 glargine 56 ankle brachial index 56 c reactive protein 56 oral antidiabetic medications 56 cholesterol triglycerides 56 chlorthalidone 56 glucose 56 UACR 56 Viral load 56 metformin sulphonylurea 56 trans fat intake 56 Homocysteine levels 56 blood Phe levels 56 fasting lipid 56 spirometry 56 carotid intima media 56 systolic blood pressure 56 LDL cholesterol levels 56 bad cholesterol LDL 56 thyroid stimulating hormone TSH 56 NSTE ACS 56 cholesterol triglyceride 56 statistical significance p 56 eosinophil count 56 mean baseline HbA1c 56 lipid profiles 56 serum calcium levels 56 VerifyNow 56 lowest tertile 56 plasma renin activity 55 thickness CIMT 55 serum CRP 55 mmHg systolic 55 uric acid levels 55 apnea hypopnea index 55 serum HBV DNA 55 serum phosphorus levels 55 nondiabetics 55 Cooper DeHoff 55 DAS# scores 55 antibody titer 55 NCEP guidelines 55 PASI scores 55 arterial elasticity 55 coronary artery calcification 55 HBV DNA levels 55 nicardipine 55 plasma glucose 55 immunochemical fecal occult 55 elevated blood glucose 55 LDL 55 inflammatory biomarkers 55 AST ALT 55 poor metabolizers 55 dietary modification 55 tHcy 55 thyroid stimulating hormone 55 d dimer 55 fructosamine 55 lowering LDL cholesterol 55 HDL C 55 serum testosterone 55 urate levels 55 skin sterol 55 urine NGAL 55 mmHg 55 Serum creatinine 55 serum cholesterol 55 prediabetes 55 sustained virologic response 55 hemoglobin A1C HbA1C 55 colorectal adenoma 55 postoperative complication 55 oxygen saturations 55 nondiabetic 55 density lipoprotein cholesterol 55 virologic response 55 lung function 55 preintervention 55 insulin glargine 55 platelet inhibition 55 erythrocyte sedimentation rate 55 antigen PSA levels 55 specific antigen PSA 55 diastolic pressure 55 Visual Analogue Scale VAS 55 NIHSS score 55 Apidra ® 55 retinal thickness 55 ng mL 55 NNT = 55 prehypertension 55 ARB telmisartan 55 serum aminotransferase levels 55 troponins 55 concomitant medications 55 residual platelet reactivity 55 International Normalized Ratio 55 Lp PLA2 55 plasma glucose levels 55 severe renal impairment 55 International Prostate Symptom 55 irbesartan 55 Fasting plasma glucose 55 #.#mmol L [001] 55 glimepiride 55 warfarin dose 55 hemoglobin concentrations 55 HDL cholesterol 55 cardio respiratory fitness 54 milligrams deciliter 54 abnormal lipid 54 aminotransferases 54 homocysteine concentrations 54 Lantus R 54 mIU L 54 fetuin 54 N telopeptide 54 mm Hg 54 serum lipid 54 anogenital distance 54 insulin detemir 54 FENO 54 spirometric 54 SUVmax 54 serum IGF 54 advanced adenomas 54 hydroxyvitamin D 54 triacylglycerol concentrations 54 x ULN 54 cholesterol 54 polyp recurrence 54 ug dl 54 oral antidiabetic drugs 54 thyroglobulin 54 postprandial glycemia 54 HBeAg seroconversion 54 posttransplant 54 FreeStyle Navigator 54 flexible sigmoidoscopy 54 transaminase levels 54 benazepril 54 pg mL 54 anticoagulation 54 undetectable viral 54 dose statin therapy 54 mean serum phosphorus 54 F2 isoprostanes 54 intravenous diuretics 54 Ambulatory Blood Pressure 54 plasma homocysteine 54 asymptomatic carotid stenosis 54 postprandial glucose 54 MADRS score 54 antidiabetic medication 54 lipid lowering agents 54 HDL cholesterol triglycerides 54 total cholesterol HDL 54 Continuous glucose 54 triglyceride levels 54 PCWP 54 β blockers 54 serum IgE 54 prehypertensive 54 cTnT 54 DEXA scans 54 Skin sterol 54 Liver biopsy 54 tPSA 54 adenoma detection 54 Diastolic pressure 54 DAS# [002] 54 Prostate specific antigen 54 isoprostane 54 advanced neoplasia 54 thyroxine 54 carotid stenosis 54 symptomatic VTE 54 magnesium intake 54 beta blocker therapy 54 coronary revascularization 54 ABPM 54 subclinical atherosclerosis 54 PSA velocity 54 UKPDS 54 improves glycemic 54 DEXA scan 54 coronary stenosis 54 lipid abnormalities 54 CVD mortality 54 lactate dehydrogenase LDH 54 elevated triglyceride levels 54 serum HCV RNA 54 angiotensin II receptor blockers 54 Non inferiority 54 adiponectin levels 54 hematocrit 54 serum concentrations 54 ADCS CGIC 54 microalbumin test 54 binary restenosis 54 mealtime insulin 54 sensitivity specificity 54 sustained virological response 54 urinary protein 54 Ishak fibrosis score 54 NovoLog ® Mix 54 nocturnal hypoglycaemia 54 severe exacerbations 54 density lipoprotein HDL cholesterol 54 serum PTH 54 statin monotherapy 54 statin therapy 54 NIHSS 54 elevated IOP 54 intraocular pressure IOP 54 bronchial hyperresponsiveness 54 fasting serum 54 elevated LDL 54 APOE e4 54 biphasic insulin aspart 54 aspirin beta blockers 54 coronary artery calcium 54 blood glucose concentrations 54 sUA levels 54 diastolic blood pressures 54 antihypertensive medication 54 low dose Iluvien 54 #.#mg/dL 54 serum cortisol 54 CI -#.# 53 Intraocular pressure 53 glycaemia 53 aspartate aminotransferase 53 ACC AHA 53 Stop Hypertension diet 53 myeloperoxidase 53 LANTUS R 53 colorectal neoplasia 53 metformin sulfonylurea 53 umol L 53 glycemic control 53 carotid bruit 53 Apgar scores 53 metabolic parameters 53 hemoglobin concentration 53 μg L 53 SHBG levels 53 pretest probability 53 CHD mortality 53 prostate specific 53 % Confidence Interval 53 testosterone supplementation 53 detemir 53 DLQI 53 glucose insulin 53 SGPT 53 urate lowering therapy 53 pressure monitoring ABPM 53 urine dipstick 53 Corus CAD 53 ejection fraction 53 thiazides 53 triglycerides 53 g dl 53 isolated systolic hypertension 53 cTnI 53 hyperglycemia 53 dose atorvastatin 53 serum vitamin D 53 hyperkalemia 53 nonvertebral fracture 53 specific IgE 53 KOMBIGLYZE XR 53 elevated serum creatinine 53 complete cytogenetic response 53 lipid lowering medications 53 abdominal circumference 53 Index CDAI score 53 cardiac troponin T 53 protein excretion 53 coronary calcium 53 subscore 53 revascularization procedures 53 plasma triglycerides 53 warfarin therapy 53 EDARBI 53 ruboxistaurin 53 Primary endpoints 53 arterial thromboembolic events 53 silent myocardial ischemia 53 candesartan 53 aminotransferase ALT 53 NHANES III 53 waist circumference 53 Lipitor #mg 53 serum folate 53 treat NNT 53 oral antidiabetes 53 Waist circumference 53 diabetes NIDDM 53 SGOT 53 abnormal cytology 53 permanently discontinue Vectibix 53 flow mediated dilation 53 dyslipidaemia 53 colesevelam HCl 53 dose clopidogrel 53 ONGLYZA 53 undetectable HCV RNA 53 deCODE BreastCancer TM 53 fraction LVEF 53 EDSS scores 53 cholesterol LDL cholesterol 53 Framingham Risk Score 53 laboratory abnormalities 53 bezafibrate 53 LV dysfunction 53 CMV infection 53 Stop Hypertension DASH diet 53 hyperphenylalaninemia HPA due 53 salivary flow 53 hemoglobin 53 transaminases 53 Glomerular filtration rate 53 Secondary efficacy endpoints 53 Insulin sensitivity 53 hypercholesterolaemia 53 ankle brachial 53 Haptoglobin 53 diabetes mellitus 53 mL/min/#.# m2 53 Ejection Fraction 53 hypoglycemic events 53 elevated homocysteine 53 blood Phe 53 nonfasting triglycerides 53 endarterectomy 53 glycated albumin 53 cardiometabolic risk 53 Glomerular Filtration Rate 53 IDDM 53 dietary sodium intake 53 intraocular pressure 53 hemoglobin Hb 53 lipid lowering therapy 53 prescribe statins 53 ATACAND 53 CPAP adherence 53 clinically meaningful reductions 53 ETDRS 53 prescribed statins 53 gm dl 53 glycemic variability 53 serum leptin 53 MELD score 53 gout flares 53 arterial stiffness 53 dose colchicine 53 fecal occult 53 corticosteroid dose 53 Beta coefficient 53 hypoglycemic episodes 52 QTcF 52 nonfatal MI 52 neutrophil count 52 nmol L 52 Insulin PH# 52 Endothelial function 52 abdominal adiposity 52 triglyceride 52 #ng/ml 52 transaminase elevations 52 intracerebral haemorrhage 52 NIH CPSI 52 #mm Hg 52 HAQ DI 52 Elitek 52 serum triglyceride 52 plasma renin 52 diastolic pressures 52 systolic dysfunction 52 GFR 52 sodium excretion 52 subclinical hyperthyroidism 52 XIENCE V PROMUS Stent 52 IPSS 52 CDAI score 52 tissue oxygenation 52 log# copies mL 52 dietary sodium 52 carotid artery intima media 52 cerebral oxygenation 52 HIV tropism 52 carotid plaque 52 NAFLD 52 plasma leptin 52 serum thyroglobulin 52 anemia hemoglobin 52 pegylated interferon alfa 52 Montgomery Asberg Depression 52 insulin degludec 52 atherogenic lipids 52 unfractionated heparin 52 abnormal lipids 52 RBP4 levels 52 adiponectin concentrations 52 blood phenylalanine Phe 52 hyperglycaemia 52 Baseline characteristics 52 exhaled nitric oxide eNO 52 perioperative mortality 52 μg dl 52 Cystatin C 52 treatment emergent AEs 52 index BMI 52 diastolic BP 52 systolic blood pressures 52 low density lipoprotein 52 anthropometric measurements 52 -#.# mg dL [001] 52 Lp PLA 2 52 Fibrates 52 oral allopurinol 52 nuchal translucency 52 Welchol 52 KDOQI 52 bilirubin 52 endometrial thickness 52 serum TSH 52 prespecified secondary 52 thyrotropin levels 52 mineral density 52 contrast induced nephropathy 52 fasting hyperglycemia 52 calcium antagonists 52 diastolic readings 52 multivariable analysis 52 nonobstructive CAD 52 Hematocrit 52 serum magnesium 52 QALE 52 inflammatory markers 52 elevated LDH 52 echocardiographic parameters 52 tumor histology 52 peginterferon alfa 2a 52 MetS 52 HCV antibody 52 hypertension diabetes mellitus 52 Ramipril 52 Oral Glucose Tolerance 52 Negative Syndrome 52 morphometric vertebral fractures 52 Nesiritide 52 gliclazide 52 tertile 52 triglyceride TG 52 QTc prolongation 52 uncorrected visual acuity 52 paricalcitol 52 Cotinine 52 recurrent venous thromboembolism 52 Masimo SpHb 52 interrater reliability 52 arterial oxygen saturation 52 serum sodium levels 52 intravascular ultrasonography 52 lipoprotein 52 mean baseline A1C 52 oxycodone CR 52 nonvertebral fractures 52 pioglitazone 52 EDSS score 52 polyp detection 52 cholesterol HDL cholesterol 52 warfarin dosage 52 serum sodium concentration 52 incontinence episodes 52 PRADAXA 52 Hypoglycaemia 52 elevated hsCRP 52 pmol L 52 stable angina 52 % CI #.#-#.# [004] 52 maximally tolerated doses 52 Avandia Actos 52 metformin hydrochloride 52 Prehypertension 52 test OGTT 52 CD4 + cell 52 acute STEMI 52 reflux symptoms 52 preoperative PSA 52 renal dysfunction 52 cholesterols 52 epithelial ovarian cancer 52 acarbose 52 metformin monotherapy 52 severe periodontitis 52 adenotonsillectomy 52 insulin sensitivity 52 grade cervical intraepithelial 52 mg/m2 dose 52 adenoma recurrence 52 Psoriasis Area 52 liver biopsies 52 glucose concentrations 52 atorvastatin #mg 52 Engerix B 52 fluvastatin 52 apoB 52 certolizumab 52 Hgb 52 subclinical hypothyroidism 52 T2DM 52 posttest 52 lowering blood glucose 52 hemodialysis patients 52 bilirubin levels 52 primary aldosteronism 52 diabetes mellitus DM 52 sodium intake 52 Complications Trial 52 gestational diabetes mellitus 52 hematological parameters 52 serum folate concentrations 52 CLA supplementation 51 definite stent thrombosis 51 ELISpot 51 #.#mmHg 51 NGAL 51 μmol L 51 hip BMD 51 Unified Parkinson Disease 51 urinary excretion 51 urinary N telopeptide 51 Colorectal cancer screening 51 STRIDE PD 51 R0 resection 51 per deciliter 51 pulmonary function 51 Blood Glucose 51 lumbar spine BMD 51 vertebral fracture 51 lowering systolic blood 51 Reynolds Risk Score 51 recurrent VTE 51 Lucentis monotherapy 51 ApoB 51 Score DAS# 51 abdominal girth 51 moderate renal impairment 51 deciliter 51 central corneal thickness 51 QIDS SR 51 periprocedural 51 COHb 51 fat vegan diet 51 PREZISTA r arm 51 confidence interval #.#-#.# 51 highest tertile 51 serum homocysteine 51 ADAS Cog 51 inhaled steroid 51 saturated fat intake 51 insulin lispro 51 digital rectal exams 51 FEV1 51 dilated eye 51 myocardial uptake 51 fats lipids 51 advanced adenoma 51 Vasotrac 51 colonoscopy flexible sigmoidoscopy 51 left ventricular hypertrophy 51 Lipid Profile 51 prescribing statins 51 tirofiban 51 impaired glucose metabolism 51 Brief Psychiatric 51 onset diabetes mellitus 51 MMSE score 51 TAXUS p value 51 plasma uric acid 51 mediated dilation 51 VTE prophylaxis 51 IU mL 51 hepatorenal syndrome 51 Microalbuminuria 51 hypercholesterolemia 51 hypercalciuria 51 DCCT 51 death reinfarction 51 salmeterol fluticasone propionate 51 baseline Hb 51 serum bicarbonate 51 glycoprotein IIb IIIa inhibitors 51 Insulin injections 51 nonpregnant adults 51 Hemoglobin A1c HbA1c 51 left ventricular ejection 51 PRADAXA #mg 51 Levemir ® 51 cerebrovascular events 51 hypogonadal men 51 HpSA 51 logistic regression analysis 51 statin medications 51 Hemoglobin 51 Triglycerides 51 NIASPAN 51 T1DM 51 Cronbach alpha 51 urinary cortisol 51 retrospective cohort 51 cotinine levels 51 8 OHdG 51 tHcy concentrations 51 cardiovascular morbidity 51 eplerenone 51 leukopenia 51 methacholine challenge 51 TRILIPIX 51 Coronary artery calcium 51 HER2 expression 51 Creatinine 51 virologic failure 51 thyrotropin 51 XIENCE V vs. 51 pg ml 51 Diovan HCT 51 telomere lengths 51 left ventricular systolic 51 biochemical recurrence 51 #OHD levels 51 angiotensin converting enzyme inhibitors 51 peginterferon 51 atypical ductal hyperplasia 51 NYHA class 51 vildagliptin 51 MDRD 51 ACE Inhibitor 51 angiotensin receptor blockers ARBs 51 TC HDL 51 cerebral oxygen saturation 51 State Examination MMSE 51 RBC transfusion 51 nonfatal stroke 51 glucose lowering 51 CK # plasma concentrations 51 #mg doses [002] 51 renal artery stenosis 51 systolic diastolic 51 pentoxifylline 51 central adiposity 51 Triglyceride 51 LDL lowering 51 ALLHAT 51 clinically meaningful improvement 51 serum selenium 51 USPSTF recommends 51 Fonarow 51 μmol l 51 hepatic fat 51 tolvaptan 51 colon rectal 51 serum markers 51 triglycerides LDL 51 Hyperlipidemia 51 postoperative morbidity 51 plasma glucose concentration 51 g dL 51 BLLs 51 LDL particle 51 nitroprusside 51 pharmacologic stress 51 Inhaled corticosteroids 51 isoflavone intake 51 hematologic toxicity 51 Coronary angiography 51 pharmacokinetic PK profile 51 prevalences 51 detectable BPA 51 abacavir 51 antihypertensive agents 51 Medication adherence 51 cardiac troponin 51 HBsAg 51 postoperative pulmonary 51 invasive coronary angiography 51 stratifying patients 51 reducing sodium intake 51 LDL cholesterol concentrations 51 alanine transaminase 51 Multivariate analysis 51 tuberculin skin testing 51 mmol liter 51 oral anticoagulation 51 systolic 51 metabolically healthy 51 pulmonary arterial 51 % CI #.#-#.# [003] 51 aspirin therapy 51 Tekamlo 51 metformin Glucophage 51 oxygen saturation 51 liver enzyme 51 oral hypoglycemic agents 51 LDL cholesterol lowering 51 Scale EDSS score 51 blood urea nitrogen 51 anticoagulation therapy 51 coronary calcification 51 Acute renal failure 51 basal bolus therapy 51 receiving Vectibix monotherapy 51 nonfatal myocardial infarction MI 51 Pioglitazone 51 thickness IMT 51 serum potassium levels 51 catheter angiography 51 retest reliability 51 Artificial pancreas 51 urinary calcium 50 cardiorespiratory fitness 50 fasting plasma 50 lanthanum carbonate 50 CYP#C# [001] 50 SpO 2 50 lipid lowering medication 50 obstructive CAD 50 warfarin 50 CCyR 50 tiotropium 50 dietary intakes 50 HSCT 50 myocardial reperfusion 50 HDL triglycerides 50 serum lipids 50 malignant nodules 50 Montgomery Åsberg Depression 50 Bone density 50 type2 diabetes 50 hemodilution 50 Severe hypoglycemia 50 paraprotein 50 odds ratios ORs 50 hours postdose 50 systolic hypertension 50 p = #.# [003] 50 Hypotension 50 symptomatic carotid stenosis 50 plasma HCV RNA 50 oral antidiabetic agents 50 hyperphosphatemia 50 conditional logistic regression 50 glycemic 50 hyperlipidaemia 50 alteplase 50 preserved ejection fraction 50 glucose tolerance test 50 Randomized clinical trials 50 abacavir lamivudine 50 dapagliflozin plus 50 candesartan cilexetil